Decoquinate Solid Solution via Hot-Melt Extrusion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimalarial drugs face challenges such as resistance, poor solubility, and toxicity, particularly in targeting the liver stage of Plasmodium parasites, necessitating the development of a new, efficient, and affordable therapeutic form of decoquinate that can effectively inhibit both liver and blood stages of the infection.
Innovation Solution
A thermal heat process is employed in a twin-screw extruder to create a solid solution formulation of decoquinate, combining it with hot-melt extrudable excipients and plasticizers, which enhances solubility and stability, allowing for the formation of a stable and effective oral dosage form that can inhibit Plasmodium parasites.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If decoquinate is formulated as traditional oral dosage, then manufacturing is simple, but solubility and bioavailability are poor
Solution Approach 1:
The patent creates a composite material system consisting of decoquinate combined with hot-melt extrudable excipients (such as hydroxypropyl methylcellulose, polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer, or vinylpyrrolidone-vinyl acetate copolymer) through hot-melt extrusion. This composite formulation enhances solubility and bioavailability while maintaining manufacturing feasibility through a controlled thermal processing approach.
Solution Approach 2:
The patent applies parameter changes by controlling the thermal processing parameters during hot-melt extrusion, including temperature profiles (heating to melting point of excipients followed by cooling), residence time, and screw rotation speed in the twin-screw extruder. These parameter adjustments enable the formation of a solid solution that improves solubility without requiring complex formulation steps.
2Reliability
If decoquinate is administered at higher doses to overcome resistance, then antimalarial effect is improved, but toxicity increases
Solution Approach 1:
The patent utilizes parameter changes in the physical state of decoquinate through hot-melt extrusion processing, transforming it into a solid solution form. This physical modification enhances dissolution rate and bioavailability, allowing lower doses to achieve the same therapeutic effect, thereby reducing toxicity while maintaining antimalarial efficacy.
3Productivity
If decoquinate is processed at high temperature to improve processing, then extrusion efficiency is improved, but drug degradation occurs
Solution Approach 1:
The patent employs hot-melt extrudable excipients as intermediary materials that facilitate the extrusion process. These excipients have melting points suitable for extrusion processing and form a matrix that protects decoquinate from thermal degradation. The excipients act as a protective medium during thermal processing, enabling efficient extrusion while maintaining drug stability.
Solution Approach 2:
The patent optimizes temperature parameters during hot-melt extrusion by heating to the melting point of the excipient material rather than using excessively high temperatures. The temperature is maintained within a range that ensures complete melting and homogeneous mixing while staying below the degradation temperature of decoquinate, thus balancing extrusion efficiency with drug stability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process results in a stable and bioavailable solid solution of decoquinate that effectively inhibits Plasmodium parasites, offering improved solubility and absorption, reducing the risk of resistance and toxicity, and providing a potent antimalarial effect.
Implementation Method 1
A thermal heat process is employed in a twin-screw extruder to create a solid solution formulation of decoquinate
Implementation Method 2
A thermal heat process is employed in a twin-screw extruder to create a solid solution formulation of decoquinate, combining it with hot-melt extrudable excipients and plasticizers
Implementation Method 3
A thermal heat process is employed in a twin-screw extruder to extrude an extrudate in the form of solid solutions
Data Source
AI summary
Hot-melt extrusion for producing solid solution comprising nanoparticle formulation of decoquinate is disclosed. Aqueous phase comprising the nanoparticles of hot-melt extruding products is homogeneous and stable. Provided is the composition comprising the solid solution of decoquinate and a method of hot-melt extrusion for producing this composition comprising the solid dispersion of decoquinate. Furthermore, provided is the solid solution comprising nanosized decoquinate formulation having improved water solubility and enhanced delivery of decoquinate in digestive system for absorption, increasing bioavailability, and the efficacy against malaria at the liver stage.